Question

A 67-year-old with nonischemic HFrEF (EF 28%) on ARNI and MRA remains symptomatic (NYHA II). BP 110/70, eGFR 72. Which class reduces HF hospitalization and CV death regardless of diabetes?

Accepted Answer

SGLT2 inhibitor

Answer

β-blocker

Answer

and MRA remains symptomatic (NYHA II). BP 110/70

Answer

eGFR 72. Which class reduces HF hospitalization and CV death regardless of diabetes?

Answer

DPP-4 inhibitor

Practice question

A 67-year-old with nonischemic HFrEF (EF 28%) on ARNI and MRA remains symptomatic (NYHA II). BP 110/70, eGFR 72. Which class reduces HF hospitalization and CV death regardless of diabetes?